Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jaundice.

J Murtagh1

  • 1Department of Community Medicine, Monash University, Box Hill Hospital,Victoria.

Australian Family Physician
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Jaundice patients require thorough history taking, suspecting drug hepatotoxins. Hepatitis A, B, and E testing is crucial; Hepatitis B carriers need monitoring to prevent chronic liver disease, cirrhosis, and cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment.

British journal of cancer·2009
Same author

Human papillomavirus (HPV) vaccines: a Canadian update.

Issues in emerging health technologies·2007
Same author

Nicotine vaccines for smoking cessation.

Issues in emerging health technologies·2007
Same author

Photoselective vaporization for benign prostatic hyperplasia.

Issues in emerging health technologies·2006
Same author

Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis.

Issues in emerging health technologies·2006
Same author

A qualitative investigation into the levers and barriers to weight loss in children: opinions of obese children.

Archives of disease in childhood·2006
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Toxicology

Background:

  • Jaundice necessitates comprehensive patient history, including travel, drug use, and contacts.
  • Hepatotoxins from medications are a significant consideration in patients presenting with jaundice.
  • Viral hepatitis, particularly Hepatitis A, B, and E, are key differential diagnoses.

Purpose of the Study:

  • To outline diagnostic approaches for jaundice, emphasizing viral hepatitis and drug-induced liver injury.
  • To differentiate between acute and past hepatitis A infection based on antibody presence.
  • To identify risk factors and diagnostic markers for chronic Hepatitis B infection and its sequelae.

Main Methods:

  • Clinical assessment including detailed travel, drug, and contact history.

Related Experiment Videos

  • Serological testing for Hepatitis A IgM and IgG antibodies.
  • Screening for Hepatitis B surface antigen (HBsAg) and Hepatitis B e antigen (HBeAg) in jaundiced patients.
  • Biochemical screening for alcohol abuse using gamma-glutamyl transferase (GGT) and mean corpuscular volume (MCV).
  • Main Results:

    • Hepatitis A IgM indicates recent infection; IgG signifies past infection and immunity. No chronic carrier state exists for Hepatitis A and E.
    • Hepatitis B surface antigen (HBsAg) testing is essential for all jaundiced patients.
    • Chronic Hepatitis B develops in 5-10% of cases, identified by persistent HBsAg and HBeAg, indicating high infectivity and risk for cirrhosis and hepatocellular carcinoma.
    • Elevated GGT and MCV levels suggest alcohol abuse.

    Conclusions:

    • A systematic approach to jaundice evaluation is critical, integrating history, serology, and biochemical markers.
    • Early identification of Hepatitis B carriers is vital for managing potential long-term complications like cirrhosis and liver cancer.
    • Screening for viral hepatitis and alcohol abuse aids in diagnosing the cause of jaundice and guiding appropriate management.